During the latest AISN Executive Board (ExBo) meeting, partners shared updates on the progress of their Working Packages.
The session placed special emphasis on finalizing the project report, which will be submitted as part of the Review Meeting with the European Commission. Partners also dedicated significant attention to the clinical trials, focusing on recent achievements and outlining the next steps to ensure their successful continuation.
The discussions helped refine the project’s strategic direction, fostering collaboration and alignment among all partners. This meeting underscored the Board’s commitment to guiding AISN toward its scientific and operational milestones.